Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Tactile paving assists visually impaired
2017-10-28

Description: ' 000 Blind Tactile Paving Tags: Blind Tactile Paving

Tactile paving is being installed at pedestrian crossings to assist
visually-impaired persons at the UFS.
Photo: Supplied

Crossing roads and accessing buildings has always been a challenge for people with visual impairments. They had to rely on peripheral sounds, such as car brakes and cues. However, after the installation of tactile paving – paving with special textures assisting the visually impaired to feel the difference between walking around on campus and crossing the road, this will no longer be a problem at the University of the Free State (UFS).

This is one of several developments that University Estates’ Department of Facilities Planning has in the pipeline for 2017 in order to ensure that the university attains its key component in providing a high-quality student experience.

Maureen Khati, Assistant Director of Project Management: Facilities Planning, says, “We saw the need to install these paving blocks in strategic spaces, as identified by the Center for Universal Access and Disability Support (CUADS).” She says these blocks will make it easier for people with visual impairments.

Special features designed to aid visually-impaired persons

These installations have special features that will assist those students and employees with limited vision or blindness to navigate through pedestrian crossings and the different campus buildings. The university chose a unique design of tactile paving that focuses on warning and directing those with visual impairments.

UFS eager to improve accessibility and mobility

The university, and all the stakeholders involved in this initiative, are delighted to be embarking on this project and are looking forward to its successful execution. To improve accessibility and mobility, more accessible entrances and exits will be built, effective signage will be installed inside and outside buildings, but the most important aspect is that dedicated seating space will be made available in lecture rooms for special-needs students.

Khati says, “More focus has been put on installing ramps in all buildings to make them more accessible for people with disabilities, as well as other needs required to enhance accessibility at the UFS.”

For the UFS, this initiative is one of many to come, as extensive research is being done and priorities are implemented accordingly.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept